• Epi proLung BL Reflex Assay
  • Biomarker mSHOX2
  • Study Data
  • Forum
  • Contact

Press Releases

14.02.2012
Epigenomics’ Epi proLung® BL Assay shows Strong Performance as Confirmation Test for Lung Cancer Diagnosis
PDF 71 KB
 
18.04.2011
Tracking Down Lung Cancer with the mSHOX2 Biomarker
PDF 38 KB
 
07.07.2010
Epigenomics AG Launches Diagnostic Lung Cancer Test in Europe
PDF 81 KB
 
23.06.2010
Epigenomics AG Successfully Validates Lung Cancer Test in Clinical Trial
PDF 72 KB
 
24.02.2010
Epigenomics AG Introduces New Lung Cancer Test at German Cancer Congress
PDF 72 KB
 
25.08.2009
Epigenomics AG: Clinical Study Shows Lead Biomarker for Lung Cancer also works in Blood
 
18.03.2009
Epigenomics AG Moves Lung Cancer Test into Development after Successful Clinical Evaluation
 
18.06.2008
Epigenomics Successfully Completes Larger Clinical Study in Early Lung Cancer Detection
 
09.06.2008
Epigenomics Successfully Completes Clinical Study in Lung Cancer Diagnosis
 
27.06.2007
Epigenomics AG Demonstrates Feasibility of Convenient Blood Test for Lung Cancer Detection in Clinical Study
 
  • Meet us
  • News
  • Feedback
© Epigenomics AG 2011 | Imprint | Disclaimer | General Terms and Conditions | Data Protection Statement 
Powered byEpigenomics AG

Please Select Your Location

Whithin the United States

International

Information for Domestic U.S. customers

I acknowledge that Epigenomics currently does not sell or make
available the lung cancer diagnostic test Epi proLung in the U.S..

CONTINUE